EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of cytochrome P4502E1 in ethanol mediated diseases: a narrative update

Samir Zakhari, Manuela Neuman, Helmut K Seitz

Alcohol and Alcoholism · 25.03.2025 · 60 (3)

DOI: 10.1093/alcalc/agaf014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alcohol and Alcoholism, online erschienen am 07.04.2025. Verfasst von Samir Zakhari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, Washington, DC, University Park, 20782, USA. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2E1, Ethanol, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 168 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytochrome P450 (CYPs) superfamily of enzymes metabolize thousands of endogenous and exogenous substrates including ethanol.

Results

Cytochrome P4502E1 (CYP2E1) is involved in ethanol metabolism as part of the so-called microsomal ethanol metabolizing system, in the metabolism of fatty acids and some drugs such as acetaminophen and isoniazid, and in the activation of a variety of procarcinogens (PCs). Chronic ethanol consumption induces CYP2E1 which may result in an enhanced metabolism of these drugs to their toxic intermediates, and in the generation of carcinogens. In addition, ethanol oxidation increases and is associated with the generation of reactive oxygen species (ROS). This oxidative stress is an important driver for the development of alcohol-associated liver disease (AALD) and alcohol-mediated cancer (AMC). ROS may bind directly to proteins and to DNA. ROS may also lead to lipid peroxidation (LPO) with the generation of LPO products. These LPO products may bind to DNA forming etheno-DNA adducts. Cell culture studies as well as animal experiments have shown that CYP2E1 knock-out animals or the inhibition of CYP2E1 by chemicals results in a significant improvement of liver histology. CYP2E1 is also involved in pathogenesis of hepatic steatosis and fibrosis. More recent studies in patients with AALD have demonstrated an improvement of serum transaminase activities when CYP2E1 was inhibited by clomethiazole. In addition to its role in the generation of ROS, CYP2E1 also enhances the activation of PCs and decreases the level of retinol and retinoic acid in the liver.

Conclusion

Inhibition of CYP2E1 may improve AALD and may inhibit AMC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2E1EthanolLiver Diseases, AlcoholicHumansAnimalsReactive Oxygen SpeciesOxidative StressCytochrome P-450 CYP2E1 InhibitorsLipid Peroxidation

Stichwörter der Autor:innen

acetaldehyde adductsalcohol mediated canceralcohol metabolismalcohol-associated liver diseasecytochrome P-450cytochrome P4502E1oxidative stressreactive oxygen speciesxenobiotic metabolism

Substanzen

Cytochrome P-450 CYP2E1EthanolReactive Oxygen SpeciesCytochrome P-450 CYP2E1 Inhibitors

Autor:innen und Institutionen

  • Independent Researcher, Washington, DC, University Park, 20782, USA.
  • In Vitro Drug Safety and Biotechnology, Toronto, ON, Canada.
  • Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
  • Centre of Liver and Alcohol Diseases, Ethianum Clinic, Heidelberg, Germany.
  • Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.

Zitieren

APA

Zakhari, S., Neuman, M., & Seitz, H. K. (2025). The role of cytochrome P4502E1 in ethanol mediated diseases: a narrative update. Alcohol and Alcoholism, 60(3). https://doi.org/10.1093/alcalc/agaf014

Vancouver

Zakhari S, Neuman M, Seitz HK. The role of cytochrome P4502E1 in ethanol mediated diseases: a narrative update. Alcohol and Alcoholism. 2025;60(3). doi:10.1093/alcalc/agaf014

BibTeX
@article{Zakhari2025,
  author = {Zakhari, Samir and Neuman, Manuela and Seitz, Helmut K},
  title = {The role of cytochrome P4502E1 in ethanol mediated diseases: a narrative update},
  journal = {Alcohol and Alcoholism},
  year = {2025},
  volume = {60},
  number = {3},
  doi = {10.1093/alcalc/agaf014}
}
Kostenlos starten →